Frijlink HW - Search Results

1

Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study.

Westerman EM, Le Brun PP, Touw DJ, Frijlink HW, Heijerman HG. Westerman EM, et al. Among authors: frijlink hw. J Cyst Fibros. 2004 Mar;3(1):23-8. doi: 10.1016/j.jcf.2003.12.005. J Cyst Fibros. 2004. PMID: 15463883 Free article. Clinical Trial.

2

Dry powder inhalation of colistin sulphomethate in healthy volunteers: A pilot study.

Westerman EM, de Boer AH, Le Brun PPH, Touw DJ, Frijlink HW, Heijerman HGM. Westerman EM, et al. Among authors: frijlink hw. Int J Pharm. 2007 Apr 20;335(1-2):41-45. doi: 10.1016/j.ijpharm.2006.11.021. Epub 2006 Nov 11. Int J Pharm. 2007. PMID: 17178200 Clinical Trial.

3

Dry powder inhalation of colistin in cystic fibrosis patients: a single dose pilot study.

Westerman EM, De Boer AH, Le Brun PP, Touw DJ, Roldaan AC, Frijlink HW, Heijerman HG. Westerman EM, et al. Among authors: frijlink hw. J Cyst Fibros. 2007 Jul;6(4):284-92. doi: 10.1016/j.jcf.2006.10.010. Epub 2006 Dec 20. J Cyst Fibros. 2007. PMID: 17185047 Free article. Clinical Trial.

4

Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.

Le Brun PP, de Boer AH, Gjaltema D, Hagedoorn P, Heijerman HG, Frijlink HW. Le Brun PP, et al. Among authors: frijlink hw. Int J Pharm. 1999 Nov 5;189(2):205-14. doi: 10.1016/s0378-5173(99)00251-3. Int J Pharm. 1999. PMID: 10536249

5

Inhalation of tobramycin in cystic fibrosis. Part 2: optimization of the tobramycin solution for a jet and an ultrasonic nebulizer.

Le Brun PP, de Boer AH, Gjaltema D, Hagedoorn P, Heijerman HG, Frijlink HW. Le Brun PP, et al. Among authors: frijlink hw. Int J Pharm. 1999 Nov 5;189(2):215-25. doi: 10.1016/s0378-5173(99)00252-5. Int J Pharm. 1999. PMID: 10536250

6

A review of the technical aspects of drug nebulization.

Le Brun PP, de Boer AH, Heijerman HG, Frijlink HW. Le Brun PP, et al. Among authors: frijlink hw. Pharm World Sci. 2000 Jun;22(3):75-81. doi: 10.1023/a:1008786600530. Pharm World Sci. 2000. PMID: 11028259 Review.

7

Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle.

de Boer AH, Le Brun PP, van der Woude HG, Hagedoorn P, Heijerman HG, Frijlink HW. de Boer AH, et al. Among authors: frijlink hw. Eur J Pharm Biopharm. 2002 Jul;54(1):17-24. doi: 10.1016/s0939-6411(02)00043-7. Eur J Pharm Biopharm. 2002. PMID: 12084498

8

Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients.

Le Brun PP, de Boer AH, Mannes GP, de Fraîture DM, Brimicombe RW, Touw DJ, Vinks AA, Frijlink HW, Heijerman HG. Le Brun PP, et al. Among authors: frijlink hw. Eur J Pharm Biopharm. 2002 Jul;54(1):25-32. doi: 10.1016/s0939-6411(02)00044-9. Eur J Pharm Biopharm. 2002. PMID: 12084499

9

Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients.

Westerman EM, Heijerman HG, Frijlink HW. Westerman EM, et al. Among authors: frijlink hw. Expert Opin Drug Deliv. 2007 Mar;4(2):91-4. doi: 10.1517/17425247.4.2.91. Expert Opin Drug Deliv. 2007. PMID: 17335406

10

Drug output of unvented jet nebulizers as a function of time.

Diederik H, Le Brun PP, Frijlink HW, Vitányi PM, Weda M, Barends DM. Diederik H, et al. Among authors: frijlink hw. Int J Pharm. 2003 May 12;257(1-2):33-9. doi: 10.1016/s0378-5173(03)00109-1. Int J Pharm. 2003. PMID: 12711159

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

297 results

Search Page